Literature DB >> 4056047

Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.

M Akmal, N Telfer, A N Ansari, S G Massry.   

Abstract

The human erythrocyte (RBC) is a target organ for parathyroid hormone (PTH) and the hormone increases RBC osmotic fragility and induces their hemolysis. The present study was undertaken to examine whether elevated blood levels of PTH affect RBC survival, and therefore whether PTH, being an extracorpuscular factor, is responsible for the shortened RBC survival in chronic renal failure. 51Cr-labeled RBC survival was elevated in six normal dogs, in six animals with chronic renal failure and secondary hyperparathyroidism (NPX), and in six thyroparathyroidectomized dogs (NPX-TPTX) with comparable degree and duration of chronic renal failure. In the normal dogs, 51Cr-labeled RBC survival ranged between 22 and 35 (25.6 +/- 1.9) d. In the NPX dogs, 51Cr-labeled RBC survival was shortened and the values ranged between 16 and 20 (18.4 +/- 0.6) d, a value significantly (P less than 0.01) lower than normal dogs. In NPX-TPTX dogs, 51Cr-labeled RBC survival ranged between 20 and 33 (25.2 +/- 1.8) d, a value not different from that in normal dogs but significantly higher (P less than 0.01) than that in NPX animals. Our data demonstrate that excess blood levels of PTH and not other consequences of the uremic state are responsible for the shortened RBC survival in chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4056047      PMCID: PMC424168          DOI: 10.1172/JCI112157

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  The anemia of renal failure.

Authors:  J F DESFORGES; J P DAWSON
Journal:  AMA Arch Intern Med       Date:  1958-02

2.  Isotope investigations of red cell production and destruction in chronic renal disease.

Authors:  R A JOSKE; J M MCALISTER; T A PRANKERD
Journal:  Clin Sci       Date:  1956-11       Impact factor: 6.124

3.  Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy.

Authors:  A I Katz; C L Hampers; J P Merrill
Journal:  Medicine (Baltimore)       Date:  1969-09       Impact factor: 1.889

4.  Hemolysis and blood loss in children with chronic renal failure.

Authors:  D E Müller-Wiefel; H Sinn; G Gilli; K Schärer
Journal:  Clin Nephrol       Date:  1977-11       Impact factor: 0.975

5.  Association of secondary hyperparathyroidism with red cell survival in chronic haemodialysis patients.

Authors:  D Saltissi; G D Carter
Journal:  Clin Sci (Lond)       Date:  1985-01       Impact factor: 6.124

Review 6.  Parathyroid hormone and the uremic manifestations.

Authors:  S G Massry
Journal:  Contrib Nephrol       Date:  1980       Impact factor: 1.580

7.  Haemolysis in chronic renal failure.

Authors:  A B Shaw
Journal:  Br Med J       Date:  1967-04-22

8.  Erythropoiesis in patients with renal failure undergoing chronic dialysis.

Authors:  J W Eschbach; D Funk; J Adamson; I Kuhn; B H Scribner; C A Finch
Journal:  N Engl J Med       Date:  1967-03-23       Impact factor: 91.245

9.  Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD).

Authors:  J E Hefti; A Blumberg; H R Marti
Journal:  Clin Nephrol       Date:  1983-05       Impact factor: 0.975

10.  Effect of parathyroid hormone on osmotic fragility of human erythrocytes.

Authors:  E Bogin; S G Massry; J Levi; M Djaldeti; G Bristol; J Smith
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

View more
  4 in total

1.  Parathyroid hormone ablation alters erythrocyte parameters that are rescued by calcium-sensing receptor gene deletion.

Authors:  Jose R Romero; Rodeler Youte; Edward M Brown; Martin R Pollak; David Goltzman; Andrew Karaplis; Lie-Chin Pong; Lawrence Chien; Naibedya Chattopadhyay; Alicia Rivera
Journal:  Eur J Haematol       Date:  2013-04-27       Impact factor: 2.997

2.  Parathyroidectomy for hyperparathyroidism associated with renal disease.

Authors:  D P O'Leary; H J White
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

3.  Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine.

Authors:  A F Perna; D Ingrosso; V Zappia; P Galletti; G Capasso; N G De Santo
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

4.  Association between carnitine deficiency and the erythropoietin resistance index in patients undergoing peritoneal dialysis: a cross-sectional observational study.

Authors:  Shohei Kaneko; Keiji Hirai; Junki Morino; Saori Minato; Katsunori Yanai; Yuko Mutsuyoshi; Hiroki Ishii; Momoko Matsuyama; Taisuke Kitano; Mitsutoshi Shindo; Akinori Aomatsu; Haruhisa Miyazawa; Yuichiro Ueda; Kiyonori Ito; Susumu Ookawara; Yoshiyuki Morishita
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.